BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 3341789)

  • 21. Inductively coupled plasma mass spectroscopy quantitation of platinum-DNA adducts in peripheral blood leukocytes of patients receiving cisplatin- or carboplatin-based chemotherapy.
    Bonetti A; Apostoli P; Zaninelli M; Pavanel F; Colombatti M; Cetto GL; Franceschi T; Sperotto L; Leone R
    Clin Cancer Res; 1996 Nov; 2(11):1829-35. PubMed ID: 9816137
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Systemic and tumor disposition of platinum after administration of cisplatin or STEALTH liposomal-cisplatin formulations (SPI-077 and SPI-077 B103) in a preclinical tumor model of melanoma.
    Zamboni WC; Gervais AC; Egorin MJ; Schellens JH; Zuhowski EG; Pluim D; Joseph E; Hamburger DR; Working PK; Colbern G; Tonda ME; Potter DM; Eiseman JL
    Cancer Chemother Pharmacol; 2004 Apr; 53(4):329-36. PubMed ID: 14673619
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Application of cisplatin as intraoperative hyperthermic peritoneal lavage (IHPL) in patients with locally advanced gastric cancer: analysis of pharmacokinetics and of nephrotoxicity.
    Kern W; Braess J; Kotschofsky M; Samel S; Becker H; Hiddemann W; Schleyer E
    Anticancer Res; 2002; 22(5):3099-102. PubMed ID: 12530050
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antitumor activity and biodistribution of cisplatin nanocapsules in nude mice bearing human ovarian carcinoma xenografts.
    Staffhorst RW; van der Born K; Erkelens CA; Hamelers IH; Peters GJ; Boven E; de Kroon AI
    Anticancer Drugs; 2008 Aug; 19(7):721-7. PubMed ID: 18594214
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacokinetics of platinum after oral or intravenous cisplatin: a phase 1 study in 32 adult patients.
    Urien S; Brain E; Bugat R; Pivot X; Lochon I; Van ML; Vauzelle F; Lokiec F
    Cancer Chemother Pharmacol; 2005 Jan; 55(1):55-60. PubMed ID: 15258698
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Low in vivo toxicity of a novel cisplatin-ursodeoxycholic derivative (Bamet-UD2) with enhanced cytostatic activity versus liver tumors.
    Dominguez MF; Macias RI; Izco-Basurko I; de La Fuente A; Pascual MJ; Criado JM; Monte MJ; Yajeya J; Marin JJ
    J Pharmacol Exp Ther; 2001 Jun; 297(3):1106-12. PubMed ID: 11356935
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacokinetics and tissue distribution of novel traditional Chinese medicine-platinum anticancer agents in rats.
    Wang X; Au-Yeung SC; Ho YP
    J Inorg Biochem; 2007 Jun; 101(6):909-17. PubMed ID: 17428541
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Serum concentration and distribution in the liver, lung, heart and kidney of platinum after hepatic arterial injection in the form of cis-diammine dichloroplatinum microcapsule in rabbits].
    Wang Y
    Zhonghua Wai Ke Za Zhi; 1990 Nov; 28(11):686-8, 704. PubMed ID: 2086077
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Tissue platinum distribution and the effect following intra-arterial injection of cisplatin to metastatic liver cancer--a case report].
    Nemoto H; Takeuchi S; Yoshizawa Y; Uemichi O; Sasaya S; Yamaguchi M; Makuuchi M; Midorikawa T; Sanada Y; Kumada K; Takizawa K
    Gan To Kagaku Ryoho; 2001 Aug; 28(8):1149-53. PubMed ID: 11525035
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Continuous or repeated prolonged cisplatin infusions in children: a prospective study on ototoxicity, platinum concentrations, and standard serum parameters.
    Lanvers-Kaminsky C; Krefeld B; Dinnesen AG; Deuster D; Seifert E; Würthwein G; Jaehde U; Pieck AC; Boos J
    Pediatr Blood Cancer; 2006 Aug; 47(2):183-93. PubMed ID: 16302218
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Plasma, renal and tumor determination of total platinum during predictive tests of chemosensitivity of human tumor implants in the renal capsule in syngeneic mice].
    Favre R; Hecquet B
    Pathol Biol (Paris); 1988 Dec; 36(10):1199-203. PubMed ID: 3070459
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Relationship between platinum-DNA adducts in leukocytes of patients with advanced germ cell cancer and survival.
    Fisch MJ; Howard KL; Einhorn LH; Sledge GW
    Clin Cancer Res; 1996 Jun; 2(6):1063-6. PubMed ID: 9816268
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacokinetic study of Cis-dichlorodiammine platinum II, in children after rapid infusion.
    Cano JP; Catalin J; Rigault JP; Bues-Charbit M; Placidi M; Raybaud C; Bernard JL
    Biomedicine; 1981 Dec; 34(3):146-53. PubMed ID: 7199945
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Flameless atomic absorption spectrophotometry analysis of cell-linked platinum after wet ashing.
    Tabary T; Millart H
    Anticancer Res; 1991; 11(1):343-6. PubMed ID: 2018370
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Influence of cellular factors and pharmacokinetics on the formation of platinum-DNA adducts in leukocytes of children receiving cisplatin therapy.
    Veal GJ; Dias C; Price L; Parry A; Errington J; Hale J; Pearson AD; Boddy AV; Newell DR; Tilby MJ
    Clin Cancer Res; 2001 Aug; 7(8):2205-12. PubMed ID: 11489793
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacokinetics and preliminary clinical data of the novel chemoprotectant BNP7787 and cisplatin and their metabolites.
    Verschraagen M; Boven E; Ruijter R; van der Born K; Berkhof J; Hausheer FH; van der Vijgh WJ
    Clin Pharmacol Ther; 2003 Aug; 74(2):157-69. PubMed ID: 12891226
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tumor-tissue and plasma concentrations of platinum during chemotherapy of non-small-cell lung cancer patients.
    Pujol JL; Cupissol D; Gestin-Boyer C; Bres J; Serrou B; Michel FB
    Cancer Chemother Pharmacol; 1990; 27(1):72-5. PubMed ID: 2173980
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Measuring cis-dichlorodiamino platinum(II) concentrations in human blood and mouth mucosa].
    Klima A; Haas G; Oremek G
    Laryngol Rhinol Otol (Stuttg); 1987 Nov; 66(11):598-600. PubMed ID: 3695774
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Peak cerebrospinal fluid platinum levels in a patient with ependymoma: evaluation of two different methods of cisplatin administration.
    DeGregorio M; Wilbur B; King O; Wallenberg J; Prewitt S; Phillips J; Wilbur J
    Cancer Treat Rep; 1986 Dec; 70(12):1437-8. PubMed ID: 3791256
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Doxorubicin and cisplatin excretion into human milk.
    Egan PC; Costanza ME; Dodion P; Egorin MJ; Bachur NR
    Cancer Treat Rep; 1985 Dec; 69(12):1387-89. PubMed ID: 4075315
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.